In this issue:
- Mark Cuban explains his anti-PBM strategy
- What physicians think about Humira biosimilars
- States go after PBMs
- HHS is confused about 340B transparency
P.S. Join my nearly 38,000 LinkedIn followers for daily links to neat stuff. You can also find my daily posts at @DrugChannels on Twitter, where I have nearly 16,000 followers.